Concepedia
Statistics
Publications
6
Citations
227
H-Index
Active since
2001
Affiliations
University of Wisconsin–Madison(Current)
University of Wisconsin Carbone Cancer Center
University of Wisconsin System
Kimberly Binger is an author at University of Wisconsin–Madison specializing in pharmacology, medicine, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyOncologyCancer TherapyPharmacokineticsUrologyAddictionDrug DiscoveryCancer Research
Publications per year
2001–2014
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
James P. Thomas, Kendra D. Tutsch, James F. Cleary et al. · Cancer Chemotherapy and Pharmacology · 2002 · 122 citations
Therapeutic Drug Monitoring, Pharmacology, Pharmacokinetic Trial +6
Phase I trial of perillyl alcohol administered four times daily continuously
Sherry Morgan-Meadows, Sarita Dubey, Michael N. Gould et al. · Cancer Chemotherapy and Pharmacology · 2003 · 26 citations
Medicine, Addiction, Addiction Medicine +6
Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors
Howard H. Bailey, Dona Alberti, James P. Thomas et al. · Clinical Cancer Research · 2007 · 25 citations · Full text
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
Noelle K. LoConte, James P. Thomas, Dona Alberti et al. · Cancer Chemotherapy and Pharmacology · 2008 · 22 citations
Advanced Cancer, Medicine, Pharmacology +7
Phase I clinical and pharmacokinetic trial of irofulven
James Thomas, Rhoda Arzoomanian, Dona Alberti et al. · Cancer Chemotherapy and Pharmacology · 2001 · 18 citations
Medicine, Pharmacokinetic Trial, Clinical Pharmacology +3
1–5 of 6